Clinical trial
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or…
NCT00336947 · Yokohama City University, Other · Unknown status
Key facts
| NCT number | NCT00336947 |
|---|---|
| Title | S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer |
| Official title | Controlled Randomized Trial to Evaluate Efficacy of Adjuvant Chemotherapy Between S-1 and UFT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Phase III Study |
| Lead sponsor | Yokohama City University, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure |
| Interventions | tegafur-gimeracil-oteracil potassium, tegafur-uracil, adjuvant therapy |
| Enrollment | 500 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2012 |
| First posted | Jun 15, 2006 |
| Last update posted | May 15, 2013 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: